Viridian Therapeutics
VRDN
VRDN
59 hedge funds and large institutions have $62.7M invested in Viridian Therapeutics in 2018 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.26% more ownership
Funds ownership: 1.72% → 1.98% (+0.26%)
Holders
59
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$8.47M | |
| 2 | +$3.5M | |
| 3 | +$2.86M | |
| 4 |
AG
Artal Group
Luxembourg
|
+$2.8M |
| 5 |
BlackRock
New York
|
+$1.64M |
Top Sellers
| 1 | -$541K | |
| 2 | -$359K | |
| 3 | -$321K | |
| 4 |
VCA
Verdence Capital Advisors
Hunt Valley,
Maryland
|
-$294K |
| 5 |
BWP
BSW Wealth Partners
Boulder,
Colorado
|
-$232K |